This chemical is primarily utilized as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. Its unique structure, featuring ferrocene and trifluoromethylphenyl groups, enhances stereoselectivity in processes such as hydrogenation, carbon-carbon bond formation, and other enantioselective transformations. It is especially effective in synthesizing pharmaceuticals and fine chemicals where high enantiomeric purity is critical. The trifluoromethyl groups improve the ligand's electron-withdrawing properties, making it suitable for reactions requiring precise control over reactivity and selectivity. Its application extends to industrial and academic research for developing advanced catalytic systems.